Abstract
Background
Little is known about the influence of chronic antithrombotic therapy on treatment and clinical outcome in patients with acute ST‐elevation myocardial infarction (STEMI).
Hypothesis
The purpose of this study was to investigate the hospital course of STEMI patients on antithrombotics.
Methods
We analyzed data of consecutive patients with STEMI, who were prospectively enrolled in the German Acute Coronary Syndromes registry between July 2000 and November 2002. Overall, 8224 patients were stratified into 3 groups: group 1 had no prior chronic antithrombotic medication (n = 6004), group 2 was on chronic acetylsalicylic acid (ASA) therapy (n = 2022), and group 3 was on chronic oral anticoagulation therapy (n = 198).
Results
Patients on antithrombotic medication were older and had a higher baseline risk profile. The rate of patients receiving early reperfusion (group 1: 74.6%, group 2: 61.2%, group 3: 52.0%) and guideline‐adherent adjustment therapy was lower among patients on antithrombotics. Age and left bundle branch block were strong negative predictors for early reperfusion therapy in patients with prior antithrombotic treatment. Infarct size measured by peak creatine kinase level was lower in patients on antithrombotics. Hospital mortality (group 1: 8.0%, group 2: 12.8%, group 3: 16.2%) and major bleeding complications (group 1: 1.6%, group 2 2.0%, group 3 4.1%) were highest in patients on oral anticoagulants. However, after adjustment for confounding factors, prior ASA (odds ratio [OR]: 0.98, 95% confidence interval [CI]: 0.80–1.21) and oral anticoagulant treatment (OR: 1.06, 95% CI: 0.66–1.71) were not independent predictors for in‐hospital death.
Conclusions
Despite a higher risk profile, patients with STEMI on a chronic antithrombotic therapy were less likely to receive early reperfusion therapy. However, after adjustment, prior ASA or oral anticoagulant therapy was not associated with higher in‐hospital mortality. Copyright © 2009 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (200.1 KB).
References
- 1.Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Effect of long‐term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 1994; 343: 499–503. [PubMed] [Google Scholar]
- 2.Antithrombotic Trialists' Collaboration. Collaborative meta‐analysis of randomised trials of antiplatelet therapy for prevention of death, myocardila infarction, and stroke in high risk patients. BMJ 2002; 324: 71–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Elwood PC, Sweetnam PM. Aspirin and secondary mortality after myocardial infarction. Lancet 1979; 2: 499–503. [DOI] [PubMed] [Google Scholar]
- 4. Alexander JH, Harrington RA, Tuttle RH, et al. Prior aspirin use predicts worse outcomes in patients with non‐ST‐elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. Am J Cardiol 1999; 83: 1147–1151. [DOI] [PubMed] [Google Scholar]
- 5. Cohen M, Adams PC, McBride R, et al. Prospective comparison of patient characteristics and outcome of non‐prior aspirin users versus aspirin users with unstable angina or non‐Q‐wave myocardial infarction treated with combination antithrombotic therapy. J Thromb Thrombolysis 1997; 4: 275–280. [DOI] [PubMed] [Google Scholar]
- 6. Lancaster GI, Lancaster CJ, Radley D, et al. Prior aspirin use in unstable angina predisposes to higher risk: the aspirin paradox. Int J Cardiol 2001; 80: 201–207. [DOI] [PubMed] [Google Scholar]
- 7. Santopinto J, Gurfinkel EP, Torres V, et al. Prior aspirin users with acute non‐ST‐elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin. Am Heart J 2001; 141: 566–572. [DOI] [PubMed] [Google Scholar]
- 8. Garcia‐Dorado D, Theroux P, Tornos P, et al. Previous aspirin use may attentuate the severity of the manifestation of acute ischemic syndromes. Circulation 1995; 92: 1743–1748. [DOI] [PubMed] [Google Scholar]
- 9. Portnay EL, Foody JM, Rathore SS, et al. Prior aspirin use and outcomes in elderly patients hospitalized with acute myocardial infarction. J Am Coll Cardiol 2005; 46: 967–974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Spencer FA, Santopinto JJ, Gore JM, et al. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2002; 90: 1056–1061. [DOI] [PubMed] [Google Scholar]
- 11. Oudot A, Steg PG, Danchin N, et al. Impact of chronic oral anticoagulation on management and outcomes of patients with acute myocardial infarction: data from the RICO survey. Heart 2006; 92: 1077–1083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Wang TY, Chen AY, Petersen ED, et al. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non‐ST‐segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative. Eur Heart J 2008; 29: 1103–1109. [DOI] [PubMed] [Google Scholar]
- 13. Friesinger GC, Smith EF. Old age, left bundle branch block and acute myocardial infarction: a vexing and lethal combination. J Am Coll Cardiol 2000; 3: 713–716. [DOI] [PubMed] [Google Scholar]
- 14. Stenestrand U, Tabrizi F, Lindbäck J, et al. Comorbidity and myocardial dysfunction are the main explanations for the higher 1‐year mortality in acute myocardial infarction with left bundle‐branch block. Circulation 2004; 110: 1896–1902. [DOI] [PubMed] [Google Scholar]
- 15. Rosengren A, Wallentin L, Simoons M, et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J 2006; 27: 789–795. [DOI] [PubMed] [Google Scholar]
- 16. Yan RT, Yan AT, Tan M, et al; for the Canadian Acute Coronary Syndromes Registry Investigators. Age‐related differences in the management and outcome of patients with acute coronary syndromes. Am Heart J 2006; 151: 352–359. [DOI] [PubMed] [Google Scholar]
- 17. De Wood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897–902. [DOI] [PubMed] [Google Scholar]